Literature DB >> 11967033

Reduced crystallization inhibition by urine from women with nephrolithiasis.

John R Asplin1, Joan H Parks, Yashushi Nakagawa, Fredric L Coe.   

Abstract

BACKGROUND: Human urine is known to inhibit growth, aggregation, nucleation, and cell adhesion of calcium oxalate monohydrate (COM) crystals, the main solid phase of human kidney stones. This study tested the hypothesis that low levels of inhibition are present in women with calcium oxalate stones and, therefore, could promote stone production.
METHODS: In 17 stone-forming women and 17 normal women matched in age within five years, inhibition by dialyzed urine proteins of COM growth and aggregation was examined, as well as whole urine upper limits of metastability (ULM) for COM and calcium phosphate (CaP) in relation to the corresponding supersaturation (SS).
RESULTS: Compared to normals, patient urine showed a reduced ULM in relation to SS. In contrast to men, there was no difference in growth inhibition.
CONCLUSIONS: Reduced CaP and CaOx ULM values in relation to SS are a characteristic of female stone formers. This defect could promote stones by facilitating crystal nucleation. Abnormal inhibition may well be a very important cause of human nephrolithiasis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11967033     DOI: 10.1046/j.1523-1755.2002.00307.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  11 in total

1.  The use of risk indices: do they predict recurrence?

Authors:  Roger A L Sutton
Journal:  Urol Res       Date:  2006-01-06

2.  Probiotics for prevention of urinary stones.

Authors:  John C Lieske
Journal:  Ann Transl Med       Date:  2017-01

Review 3.  Kidney stone disease.

Authors:  Fredric L Coe; Andrew Evan; Elaine Worcester
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

4.  Aggregation of freshly precipitated calcium oxalate crystals in urine of calcium stone patients and controls.

Authors:  J M Baumann; B Affolter; R Casella
Journal:  Urol Res       Date:  2011-05-13

5.  Progressive renal papillary calcification and ureteral stone formation in mice deficient for Tamm-Horsfall protein.

Authors:  Yan Liu; Lan Mo; David S Goldfarb; Andrew P Evan; Fengxia Liang; Saeed R Khan; John C Lieske; Xue-Ru Wu
Journal:  Am J Physiol Renal Physiol       Date:  2010-06-30

Review 6.  From crystalluria to kidney stones, some physicochemical aspects of calcium nephrolithiasis.

Authors:  Johannes M Baumann; Beat Affolter
Journal:  World J Nephrol       Date:  2014-11-06

7.  Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle.

Authors:  Andrew P Evan; James E Lingeman; Fredric L Coe; Joan H Parks; Sharon B Bledsoe; Youzhi Shao; Andre J Sommer; Ryan F Paterson; Ramsay L Kuo; Marc Grynpas
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

8.  Contrasting histopathology and crystal deposits in kidneys of idiopathic stone formers who produce hydroxy apatite, brushite, or calcium oxalate stones.

Authors:  Andrew P Evan; James E Lingeman; Elaine M Worcester; Andre J Sommer; Carrie L Phillips; James C Williams; Fredric L Coe
Journal:  Anat Rec (Hoboken)       Date:  2014-01-30       Impact factor: 2.064

9.  Urine risk factors in children with calcium kidney stones and their siblings.

Authors:  Kristin J Bergsland; Fredric L Coe; Mark D White; Michael J Erhard; William R DeFoor; John D Mahan; Andrew L Schwaderer; John R Asplin
Journal:  Kidney Int       Date:  2012-02-22       Impact factor: 10.612

10.  New pathophysiological aspects of growth and prevention of kidney stones.

Authors:  J M Baumann; B Affolter
Journal:  Adv Urol       Date:  2012-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.